Your browser doesn't support javascript.
loading
Synthesis, Characterization, and in vivo Evaluation of a Novel Potent Autotaxin-Inhibitor.
Hunziker, Daniel; Reinehr, Sabrina; Palmhof, Marina; Wagner, Natalie; Biniasch, Thomas; Stute, Gesa; Mattei, Patrizio; Schmitz, Petra; DiGiorgio, Patrick; Hert, Jérôme; Rudolph, Markus G; Benz, Joerg; Stihle, Martine; Gsell, Bernard; Müller, Stephan; Gasser, Rodolfo; Schonhoven, Nina; Ullmer, Christoph; Joachim, Stephanie C.
Afiliação
  • Hunziker D; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Therapeutic Modalities, Small Molecule Research, Roche Innovation Center Basel, Basel, Switzerland.
  • Reinehr S; Experimental Eye Research Institute, University Eye Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Palmhof M; Experimental Eye Research Institute, University Eye Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Wagner N; Experimental Eye Research Institute, University Eye Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Biniasch T; Experimental Eye Research Institute, University Eye Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Stute G; Experimental Eye Research Institute, University Eye Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Mattei P; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Therapeutic Modalities, Small Molecule Research, Roche Innovation Center Basel, Basel, Switzerland.
  • Schmitz P; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Therapeutic Modalities, Small Molecule Research, Roche Innovation Center Basel, Basel, Switzerland.
  • DiGiorgio P; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Therapeutic Modalities, Small Molecule Research, Roche Innovation Center Basel, Basel, Switzerland.
  • Hert J; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Therapeutic Modalities, Small Molecule Research, Roche Innovation Center Basel, Basel, Switzerland.
  • Rudolph MG; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Therapeutic Modalities, Small Molecule Research, Roche Innovation Center Basel, Basel, Switzerland.
  • Benz J; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Therapeutic Modalities, Small Molecule Research, Roche Innovation Center Basel, Basel, Switzerland.
  • Stihle M; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Therapeutic Modalities, Small Molecule Research, Roche Innovation Center Basel, Basel, Switzerland.
  • Gsell B; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Therapeutic Modalities, Small Molecule Research, Roche Innovation Center Basel, Basel, Switzerland.
  • Müller S; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Therapeutic Modalities, Small Molecule Research, Roche Innovation Center Basel, Basel, Switzerland.
  • Gasser R; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Therapeutic Modalities, Small Molecule Research, Roche Innovation Center Basel, Basel, Switzerland.
  • Schonhoven N; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland.
  • Ullmer C; Experimental Eye Research Institute, University Eye Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Joachim SC; F. Hoffmann-La Roche Ltd., Pharma Research and Early Development, Ophthalmology Discovery, Roche Innovation Center Basel, Basel, Switzerland.
Front Pharmacol ; 12: 699535, 2021.
Article em En | MEDLINE | ID: mdl-35126098
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article